PVLA – palvella therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting
Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal [Yahoo! Finance]
Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win [Yahoo! Finance]
Palvella Therapeutics (PVLA) had its price target raised by HC Wainwright from $255.00 to $270.00. They now have a "buy" rating on the stock.
Palvella Therapeutics to Host Full Year 2025 Financial Results Conference Call and Provide a Corporate Update on March 31, 2026 [TheStreet.com]
Form 4 PALVELLA THERAPEUTICS, For: Mar 18 Filed by: Goin Kathleen
Form 144 PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Form 4 PALVELLA THERAPEUTICS, For: Feb 27 Filed by: JENKINS GEORGE M
Form 4 PALVELLA THERAPEUTICS, For: Feb 27 Filed by: HERON ELAINE J
Form 8-K PALVELLA THERAPEUTICS, For: Feb 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.